Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹11Cr
Rev Gr TTM
Revenue Growth TTM
53,600.00%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

JINDCOT
VS
| Quarter | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|
|
Growth YoY Revenue Growth YoY% | -74.1 | -64.2 | -100.0 | -100.0 | -100.0 | -99.6 | | | | -100.0 | | |
| 24 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 6 |
Operating Profit Operating ProfitCr |
| -994.5 | 68.8 | | | | -5,700.0 | | | | | | -6.5 |
Other Income Other IncomeCr | 115 | 1 | 8 | 1 | 2 | 0 | 1 | 9 | -5 | 1 | 1 | 1 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 92 | 2 | 7 | 1 | 1 | 0 | 0 | 8 | -6 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 6,976.1 | 292.1 | 473.6 | -94.2 | -99.2 | -116.4 | -100.1 | 1,008.2 | -904.2 | 144.4 | 300.0 | -101.7 |
| 4,188.2 | 89.8 | | | | -3,600.0 | | | | | | -2.6 |
| 20.5 | 0.5 | 1.6 | 0.0 | -0.2 | -0.1 | 0.0 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|
|
| | -43.8 | -48.1 | 75.1 | 31.7 | -64.2 | -60.8 | -13.3 | -46.5 | -84.0 | -99.6 | 53,600.0 |
| 341 | 253 | 114 | 179 | 242 | 80 | 34 | 28 | 38 | 2 | 2 | 7 |
Operating Profit Operating ProfitCr |
| 2.2 | -29.2 | -12.4 | -0.8 | -3.5 | 4.5 | -2.3 | 1.1 | -150.0 | 1.8 | -21,300.0 | -28.1 |
Other Income Other IncomeCr | 3 | 1 | 2 | 2 | 2 | 16 | 24 | 2 | 131 | 12 | 5 | -3 |
Interest Expense Interest ExpenseCr | 48 | 59 | 62 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 12 | 19 | 20 | 20 | 20 | 6 | 6 | 6 | 5 | 0 | 0 | 0 |
| -50 | -134 | -93 | -20 | -28 | 13 | 16 | -5 | 102 | 11 | 2 | -6 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| | -168.8 | 30.8 | 78.8 | -43.7 | 145.7 | 25.2 | -131.0 | 2,121.7 | -89.2 | -82.5 | -397.9 |
| -14.3 | -68.6 | -91.5 | -11.1 | -12.1 | 15.4 | 49.3 | -17.6 | 666.3 | 451.4 | 19,300.0 | -107.1 |
| -11.1 | -30.6 | -18.4 | -4.5 | -6.3 | 2.9 | 3.6 | -1.1 | 22.6 | 2.4 | | -0.1 |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|
Equity Capital Equity CapitalCr | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
| 236 | 60 | -33 | -49 | -72 | 17 | 33 | 28 | 130 | 141 | 143 | 143 |
Current Liabilities Current LiabilitiesCr | 228 | 162 | 171 | 187 | 85 | 20 | 14 | 14 | 21 | 9 | 7 | 7 |
Non Current Liabilities Non Current LiabilitiesCr | 316 | 425 | 478 | 475 | 591 | 237 | 212 | 209 | 51 | 42 | 41 | 41 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 392 | 329 | 319 | 332 | 370 | 201 | 194 | 192 | 189 | 180 | 179 | 179 |
Non Current Assets Non Current AssetsCr | 436 | 367 | 346 | 327 | 275 | 118 | 111 | 104 | 57 | 56 | 57 | 57 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|
Operating Cash Flow Operating Cash FlowCr | 45 | -79 | -50 | 2 | 6 | 93 | 24 | 3 | 113 | 6 | 0 |
Investing Cash Flow Investing Cash FlowCr | -32 | -6 | 1 | 1 | -3 | 274 | 2 | 2 | 45 | 4 | 2 |
Financing Cash Flow Financing Cash FlowCr | 1 | 73 | 46 | -5 | -3 | -374 | -26 | -4 | -159 | -10 | -2 |
|
Free Cash Flow Free Cash FlowCr | 31 | -67 | -43 | 1 | 4 | 92 | 24 | 3 | 157 | 8 | |
| -89.4 | 58.6 | 54.3 | -10.2 | -22.3 | 719.2 | 149.5 | -68.8 | 111.4 | 50.8 | -2.6 |
CFO To EBITDA CFO To EBITDA% | 587.8 | 137.8 | 401.9 | -147.8 | -75.8 | 2,487.3 | -3,190.8 | 1,062.4 | -494.9 | 12,620.1 | 2.4 |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 68 | 37 | 38 | 59 | 32 | 21 | 9 | 11 | 17 | 0 | |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.6 | 0.5 | 0.0 | 0.2 | 0.0 | |
Price To Sales Price To Sales | 0.2 | 0.2 | 0.4 | 0.3 | 0.1 | 0.3 | 0.3 | 0.4 | 1.1 | 0.0 | |
Price To Book Price To Book | 0.2 | 0.3 | 3.1 | -14.9 | -1.2 | 0.3 | 0.1 | 0.1 | 0.1 | 0.0 | |
| 59.5 | -9.9 | -50.0 | -489.7 | -76.0 | 69.9 | -295.5 | 681.7 | -3.1 | 1,020.5 | |
Profitability Ratios Profitability Ratios |
| 17.9 | 24.4 | 23.2 | 22.6 | 21.1 | 23.7 | 35.2 | 39.3 | 43.3 | 82.1 | 100.0 |
| 2.2 | -29.2 | -12.4 | -0.8 | -3.5 | 4.5 | -2.3 | 1.1 | -150.0 | 1.8 | -21,300.0 |
| -14.3 | -68.6 | -91.5 | -11.1 | -12.1 | 15.4 | 49.3 | -17.6 | 666.3 | 451.4 | 19,300.0 |
| -0.3 | -11.7 | -5.0 | -3.1 | -4.6 | 4.5 | 5.8 | -1.5 | 44.8 | 5.3 | 1.3 |
| -17.8 | -128.0 | -771.2 | 498.0 | 105.5 | 20.9 | 20.8 | -6.9 | 58.2 | 5.9 | 1.0 |
| -6.0 | -19.3 | -13.9 | -3.0 | -4.4 | 4.0 | 5.3 | -1.7 | 41.3 | 4.7 | 0.8 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
This report provides a comprehensive overview of the company’s current standing, focusing on its governance framework, the total cessation of its industrial operations, and the critical financial and regulatory challenges it currently faces.
---
### **Governance Framework & Leadership Structure**
Despite operational halts, the company maintains a formal corporate governance structure designed to oversee strategic decisions and regulatory compliance. The leadership model is built around a **Board of Directors** supported by specialized committees to ensure fiduciary responsibility.
* **Board Composition & Expertise**: The board is composed of individuals with significant domain expertise, including directors with over **35 years** of experience in the industrial sector. The selection process emphasizes a **skill-based composition** to align with the specific requirements of the business services sector.
* **Specialized Oversight Committees**:
* **Audit Committee**: Responsible for financial oversight and internal controls.
* **Nomination & Remuneration Committee (NRC)**: Manages the alignment of leadership capabilities with long-term business goals.
* **Stakeholders Relationship Committee**: Focuses on safeguarding the interests of shareholders and other stakeholders.
* **Independent Director Mandates**:
* Independent Directors serve standard terms of **5 consecutive years**.
* The current re-appointment cycle for key independent leadership spans from **September 29, 2023**, to **September 28, 2028**.
* Appointments are formalized via **Special Resolution** by members.
* To ensure continuity in strategic oversight, Independent Directors are **not liable to retire by rotation**.
---
### **Operational Status: Total Cessation of Activities**
The company is currently in a state of operational paralysis, with all primary revenue-generating activities halted.
* **Manufacturing Shutdown**: There are currently **no manufacturing activities** being conducted. The company’s core industrial facilities are inactive.
* **Energy Sector Exit**: Operations at the **Jaisalmer wind mill** have been closed. This closure was necessitated by the non-payment of essential maintenance charges to **Suzlon**, the service provider.
* **Subsidiary & Investment Uncertainty**: There is a lack of clarity regarding the company’s unquoted investments in its subsidiary, **Jindal International FZE**, and capital advances made to **K. Onishi & Co.**, as these have not been evaluated under current **Ind AS** standards.
---
### **Financial Distress & Debt Resolution Status**
The company’s financial position is characterized by heavy indebtedness, **NPA (Non-Performing Asset)** classifications, and ongoing recovery actions by lenders.
#### **Lender Relations and Recovery Actions**
All accounts with banks and financial institutions are classified as **NPA**. Lenders have recalled all outstanding dues and initiated recovery proceedings under the **SARFAESI Act, 2002**. However, the company maintains a legal stance that certain debts to secured lenders are **barred by limitation**, as the defaults are older than **three years**.
#### **Debt Settlement Progress (OTS)**
The company is attempting to clear liabilities through **One Time Settlements (OTS)**, with the following status across various creditors:
| Entity | Liability Type | Status | Financial Details |
| :--- | :--- | :--- | :--- |
| **Union Bank of India** | Secured Debt | **Defaulted on OTS** | **₹3.00 Crore** sanctioned; only **₹0.75 Crore** paid by March 2024. |
| **Punjab & Sind Bank** | Secured Debt | **In Process** | Settlement negotiations are currently ongoing. |
| **PSPCL (Electricity)** | Utility Dues | **Settled** | Old dues of **₹99.31 Lacs** paid in full. |
| **Statutory Bodies** | VAT, ESI, EPF | **Outstanding** | Long-term liabilities remain unpaid. |
#### **Contingent Liabilities & Guarantees**
The company faces massive exposure through corporate guarantees provided to related entities, totaling **₹256.10 Crore**. These guarantees were issued to:
1. **Jindal Medicot Ltd**: Currently under **CIRP** (Corporate Insolvency Resolution Process).
2. **Jindal Specialty Textiles Ltd**.
---
### **Regulatory Compliance & Market Standing**
The company is currently isolated from the capital markets due to a series of regulatory infractions and historical bans.
* **Stock Exchange Suspension**: Trading of the company’s equity shares is suspended on both the **BSE** and **NSE**. This is a result of non-compliance with listing agreements, non-payment of annual listing fees, and outstanding fines.
* **SEBI Restraint Order**: The company and its directors were barred from the securities market for a period of **five years**, effective **April 24, 2019**. While this period expired on **April 23, 2024**, the company has not yet formalized the removal of this barring and remains in the process of addressing the fallout.
* **Audit Qualifications & "Emphasis of Matter"**:
* **Balance Confirmations**: Auditors have noted the total absence of third-party confirmations for **Trade Receivables, Trade Payables, and Loans & Advances**.
* **Employee Benefits**: The company has failed to apply **Ind AS 19** regarding employee benefits due to a lack of required actuarial valuations.
* **Accounting Standards**: Non-application of **Ind AS** regarding unquoted investments and specific capital advances remains a critical transparency gap.
---
### **Strategic Risk Summary**
Investors should note the following critical risk factors:
* **Liquidity Risk**: Failure to meet **OTS** deadlines (e.g., Union Bank) suggests severe cash flow constraints.
* **Legal Risk**: Ongoing **SARFAESI** actions and the potential for further litigation regarding the **₹256.10 Crore** in corporate guarantees.
* **Compliance Risk**: Continued suspension from stock exchanges prevents any immediate liquidity for shareholders.
* **Operational Risk**: The lack of any active manufacturing or energy production means the company currently has no organic path to revenue generation.